MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...

Cirius Therapeutics, Inc., developing innovative therapies for patients suffering from diseases caused by insulin resistance, ...

The poster presented at the meeting will be made available on the Glucotrack website following the conference.

Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee) announced that it presented interim results from a global ...

Fashion met science recently as an interdisciplinary team of undergraduate fashion merchandising and biochemistry students ...

Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage ...

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) has achieved a major milestone in the fight against acute myeloid leukemia ...

It always takes a village to organise an event the size of the EASL Congress. We had close to 8,000 registrants, so it was a ...

Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

The department of biochemistry, Father Muller Medical College, Kankanady, hosted the inauguration of the 10th annual state ...

The University of Sharjah (UoS), through its Center of Excellence for Public Health (CEPH) under the Research Institute for Medical and Health ...